Oscine Therapeutics IVS — Credit Rating and Financial Key Figures

Oscine Therapeutics IVS (CVR number: 38663062) is a company from KØBENHAVN. The company recorded a gross profit of -1.4 kDKK in 2018. The operating profit was -1.4 kDKK, while net earnings were -1.4 kDKK. The profitability of the company measured by Return on Assets (ROA) was -19.9 %, which can be considered poor and Return on Equity (ROE) was -22.5 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 77.5 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. Oscine Therapeutics IVS's liquidity measured by quick ratio was 4.4 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.